Structure-function and biological role of betacellulin

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 8, 2000, Pages 805-815

  Dunbar, Andrew J ^a   Goddard, Chris ^b  

^a CSIRO   (Australia)

^b GroPep Ltd   (Australia)

Author keywords

Betacellulin; EGF family; ErbB; Pancreas

Indexed keywords

BETACELLULIN; EPIDERMAL GROWTH FACTOR;

AMINO ACID SEQUENCE; DISULFIDE BOND; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034255462     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(00)00028-5     Document Type: Review

References (69)

1. van der Greer P., Hunter T., Lindberg R.A. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10:1994;251-337.
2. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;4489-4492.
3. Lemmon M.A., Schlessinger J. Regulation of signal transduction by receptor oligomerization. Trends Biochem. Sci. 19:1994;459-463.
4. Heldin C.H., Ostman A. Ligand-induced dimerization of growth factor receptors: variations on the theme. Cyt. Growth. Fact. Rev. 7:1996;3-10.
5. Cohen G.B., Ren R., Baltimore D. Modular binding domains in signal transduction proteins. Cell. 80:1995;237-248.
6. Kavanaugh W.M., Williams L.T. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science. 266:1994;1862-1865.
7. Alroy I., Yarden Y. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 410:1997;83-86.
8. Savage C.R., Inagami T., Cohen S. The primary structure of epidermal growth factor. J. Biol. Chem. 247:1972;7612-7621.
9. Marquardt H., Hunkapiller M.W., Hood L.E., Todaro G.J. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science. 223:1984;1079-1082.
10. Higashiyama S., Abraham J.A., Miller J., Fiddes J.C., Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 251:1991;936-939.
11. Toyoda M., Komuraski T., Uchida D., Takayama Y., Isobe T., Okuyama T., Hanada K. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat hepatocytes. J. Biol. Chem. 270:1995;7495-7500.
12. Shoyab M., Plowman G.D., McDonald V.L., Bradley J.G., Todaro G.J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science. 24:1989;1074-1076.
13. Marchionni M.A., Goodearl A.D., Chen M.S., Bermingham-McDonough O., Kirk C., Hendricks M., Danehy F., Misumi D., Sudhalter J., Kobayashi K. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature. 362:1993;312-318.
14. Chang H., Riese II D.J., Gilbert W., Stern D.F., McMahan U.J. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature. 387:1997;509-512.
15. Carraway III K.L., Weber J.L., Unger M.J., Ledesma Y., Yu J.N., Gassmann M., Lai C. Neuregulin 2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature. 387:1997;512-516.
16. Zhang D., Sliwkowski M.X., Mark M., Frantz G., Akita R., Sun Y., Hillan K., Crowley C., Brush J., Godowski P.J. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc. Natl. Acad. Sci. (USA). 94:1997;9562-9567.
17. Harari D., Tzahar E., Romano J., Shelly M., Pierce J.H., Andrews G.C., Yarden Y. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene. 18:1999;2681-2689.
18. Shing Y., Christofori G., Ono Y., Sasada R., Igarashi K., Folkman J. Betacellulin: a mitogen from pancreatic beta cell tumors. Science. 259:1993;1604-1607.
19. Sasada R., Ono Y., Taniyama Y., Shing Y., Folkman J., Igarashi K. Cloning and expression of cDNA encoding human betacellulin, a new member of the EGF family. Biochem. Biophys. Res. Commun. 190:1993;1173-1179.
20. Dunbar A.J., Priebe I.K., Belford D.A., Goddard C. Identification of betacellulin as a major peptide growth factor in milk: purification, characterization and molecular cloning of bovine betacellulin. Biochem. J. 344:1999;713-721.
21. Pathak B.G., Gilbert D.J., Harrison C.A., Luetteke N.C., Chen X., Klagsbrun M., Plowman G.D., Copeland N.G., Jenkins N.A., Lee D.C. Mouse chromosomal location of three EGF receptor ligands: amphiregulin (Areg), betacellulin (btc), and heparin-binding EGF (HB-EGF). Genomics. 28:1995;116-118.
22. Seno M., Tada H., Kosaka M., Sasada R., Igarashi K., Shing Y., Folkman J., Ueda M., Yamada H. Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form. Growth Factors. 13:1996;181-191.
23. Watanabe H., Shintani A., Nakata M., Shing Y., Folkman J., Igarsahi K., Sasada R. Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction. J. Biol. Chem. 269:1994;9966-9973.
24. Tada H., Sasada R., Kawaguchi Y., Kojima I., Gullick W.J., Salomon D.S., Igarashi K., Seno M., Yamada H. Processing and juxtacrine activity of membrane-anchored betacellulin. J. Cell. Biochem. 72:1999;423-434.
25. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., Russell W.E., Castner B.J., Johnson R.S., Fitzner J.N., Boyce R.W., Nelson N., Kozlosky C.J., Wolfson M.F., Rauch C.T., Cerretti D.P., Paxton R.J., March C.J., Black R.A. An essential role for ectodomain shedding in mammalian development. Science. 282:1998;1281-1284.
26. Izumi Y., Hirata M., Hasuwa H., Iwamoto R., Umata T., Miyado K., Tamai Y., Kurisaki T., Sehara-Fujisawa A., Ohno S., Mekada E. A metalloprotease-distintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17:1998;7260-7272.
27. Fan H., Derynck R. Ectodomain shedding of TGF-α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 18:1999;6962-6972.
28. Getchman Z., Alonso J.L., Raab G., Ingber D.E., Klagsbrun M. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J. Biol. Chem. 274:1999;28828-28835.
29. Prenzel N., Zwick E., Daub H., Leserer M., Reimar A., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:1999;884-888.
30. Riese II D.J., Bermigham Y., van Raaj T.M., Buckley S., Plowman G.D., Stern D.F. Betacellulin activates the epidermal growth factor receptor and erbB-4 and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neurgulin-beta. Oncogene. 12:1996;345-353.
31. Elenius K., Paul S., Allison G., Sun J., Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 16:1997;1268-1278.
32. Peles E., Ben-Levy R., Tzahar E., Liu N., Wen D., Yarden Y. Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER2 suggests complex ligand-receptor relationships. EMBO J. 12:1993;961-971.
33. erbB4. Nature. 366:1993;473-475.
34. Sliwkowski M.X., Schaefer G., Akita R.W., Lofgren J.A., Fitzpatrick V.D., Nuijens A., Fendly B.M., Cerione R.A., Vandlen R.L., Carraway III K.L. Coexpression of ErbB2 and ErbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem. 269:1994;14661-14665.
35. Tzahar E., Levkowitz G., Karunagaran D., Yi L., Peles E., Lavi S., Chang D., Liu N., Yayon A., Wen D., Yarden Y. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J. Biol. Chem. 269:1994;25226-25233.
36. Busfield S.J., Michnick D.A., Chickering T.W., Revett T.L., Ma J., Woolf E.A., Comrack C.A., Dussault B.J., Woolf J., Gooderal A.D., Gearing D.P. Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus. Mol. Cell Biol. 17:1997;4007-4014.
37. Zhang D., Sliwkowski M.X., Mark M., Frantz G., Akita R., Sun Y., Hillan K., Crowley C., Brush J., Godowski P.J. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc. Natl. Acad. Sci. (USA). 94:1997;9562-9567.
38. Hynes N.E., Stern D.F. The biology of erbB-2/neu/HER2 and its role in cancer. Biochim. Biophys. Acta. 1198:1994;165-184.
39. Tzahar E., Pinkas-Kramarski R., Moyer J., Klapper L.N., Alroy I., Levkowitz G., Shelly M., Henis S., Eisenstein M., Ratzkin B.J., Sela M., Andrews G.C., Yarden Y. Bivalency of EGF-like ligands drives the ErbB signaling network. EMBO J. 16:1997;4938-4950.
40. Graus-Porta D., Beerli R., Daly J.M., Hynes N.E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16:1997;1647-1655.
41. Klapper L.N., Glathe S., Vaisman N., Hynes N.E., Andrews G.C., Sela M., Yarden Y. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc. Natl. Acad. Sci. (USA). 96:1999;4995-5000.
42. Pinkas-Kramarski R., Leferink A.E.G., Bacus S.S., Lyass L., van der Poll M.L.M., Klapper L.N., Tzahar E., Sela M., van Zoelen E.J.J., Yarden Y. The oncogenic erbB-2/erbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin. Oncogene. 16:1998;1249-1258.
43. Alimandi M., Wang L.-M., Bottaro D., Lee C.-C., Kuo A., Frankel M., Fedi P., Tang C., Lippman M., Pierce J.H. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J. 16:1997;5608-5617.
44. Wang L.M., Kuo A., Alimandi M., Veri M.C., Lee C.-C., Kapoor V., Ellmore N., Chen X.-H., Pierce J.H. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Proc. Natl. Acad. Sci. (USA). 95:1998;6809-6814.
45. Muthuswamy S.K., Gilman M., Brugge J.S. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol. Cell Biol. 19:1999;6845-6857.
46. C. Sweeny, C. Lai, D.J. Riese II, A.J. Diamonti, L.C. Cantley, K.L. Carraway III, Ligand discrimination in signalling through an ErbB4 receptor homodimer, J. Biol. Chem. 2000, in press.
47. Yokoyama M., Funatomi H., Kobrin M.S., Ebert M., Friess H., Buchler M.W., Korc M. Betacellulin, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer. Int. J. Oncol. 7:1995;825-829.
48. Kawaguchi M., Hosotani R., Kogire M., Ida J., Doi R., Koshiba T., Miyamoto Y., Tsuji S., Nakajima S., Kobayashi H., Masui T., Imamura M. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells. Int. J. Oncol. 16:2000;37-41.
49. Barnard J.A., Graves-Deal R., Pittelkow M.R., DuBois R., Cook P., Ramsey G.W., Bishop P.R., Damstrup L., Coffey R.J. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. J. Biol. Chem. 269:1994;22817-22822.
50. Kiguchi K., Beltran L., Rupp T., DiGiovanni J. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol. Mol. Carcin. 22:1998;73-83.
51. Ha-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res. 55:1995;1883-1893.
52. Mann B., Fowler K.J., Gabriel A., Nice E.C., Williams R.L., Dunn A.R. Mice with a null mutation of the TGF-α gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell. 73:1993;249-261.
53. Luetteke N.C., Qiu T.H., Peiffer R.L., Oliver P., Smithies O., Lee D.C. TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 73:1993;263-278.
54. Luetteke N.C., Qiu T.H., Fenton S.E., Troyer K.L., Riedel R.F., Chang A., Lee D.C. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development. 126:1999;2739-2750.
55. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:1995;2354-2380.
56. Threadgill D.W., Dlgosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., LaMantia C., Mourton T., Herrup K., Harris R.C., Barnard J.A., Yuspa S.H., Coffey R.J. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 269:1995;230-234.
57. Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., Derynck R. Epithelial immaturity and multi-organ failure in mice lacking epidermal growth factor receptor. Nature. 376:1995;337-341.
58. Lee K.F., Simon H., Chen H., Bates B., Hung M.C., Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature. 378:1995;394-398.
59. Erickson S.L., O'Shea K.S., Ghaboos N., Loverro L., Frantz G., Bauer M., Lu L.H., Moore M.W. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice. Development. 124:1997;4999-5011.
60. Gassmann M., Casagranda F., Orioli D., Simon H., Lai C., Klein R., Lemke G. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature. 378:1995;390-394.
61. Mashima H., Ohnishi H., Wakabayashi K., Mine T., Miyagawa J., Hanafusa T., Seno M., Yamada H., Kojima I. Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J. Clin. Invest. 97:1996;1647-1654.
62. Watada H., Kajimoto Y., Miyagawa J., Hanafusa T., Hamaguchi K., Matsuoka T.A., Yamamoto K., Matsuzawa Y., Kawamori R., Yamasaki Y. Pdx-1 induces insulin and glucokinase expressions in α-TC 1 clone 6 cells in the presence of betacellulin. Diabetes. 45:1996;1826-1831.
63. Huotari M.A., Palgi J., Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells; identification of betacellulin as a novel β-cell mitogen. Endocrinology. 139:1998;1494-1499.
64. Miyagawa J., Hanafusa O., Sasada R., Yamamoto K., Igarashi K., Yamamori K., Seno M., Tada H., Nammo T., Li M., Yamagata K., Nakajima H., Namba M., Kuwajima M., Matsuzawa Y. Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. Endocr. J. 46:1999;755-764.
65. Sundaresan S., Roberts P.E., King K.L., Sliwkowski M.X., Mather J.P. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression. Endocrinology. 139:1998;4756-4764.
66. Kulkarni R.N., Bruning J.C., Winay J.N., Postic C., Magnuson M.A., Kahn C.R. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 96:1999;329-339.
67. Ahlgren V., Jonsson J., Jonsson L., Simu K., Edlund H. β-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes. Genes and Dev. 12:1998;1763-1768.
68. Beerli R.R., Hynes N.E. Epidermal growth factor-related peptides activate distinct subsets of erbB receptors and differ in their biological activities. J. Biol. Chem. 271:1996;6071-6076.
69. Daly J.M., Olayioye M.A., Wong A.M.-L., Neve R., Lane H.A., Maurer F.G., Hynes N.E. NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways. Oncogene. 18:1999;3440-3451.